Please assess the completion status of the following clinical trial:

Trial Title: Pleiotropic Effects of Atorvastatin in High Cardiovascular Risk Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: BASIC_SCIENCE
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients with coronary artery disease confirmed by coronary angiography.~* Patients undergoing cardiac surgery such as elective coronary bypass artery grafting (CABG), valve replacement or aortic surgery.~* All patients will not be under statins treatment for at least 6 months before their inclusion to the study.~Exclusion Criteria:~* Acute coronary syndrome during the last 2 months~* Renal failure (creatinine \> 2,2 mg/dl)~* Severe liver disease. Prospective follow-up of liver enzymes will be performed by the physicians in charge, as indicated by the relative guidelines regarding statins use and according to the current clinical practice.~* Any chronic/acute inflammatory disease, autoimmune disease and/or cancer~* Use of anti-inflammatory drugs or vitamins supplements

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 80 Years
- Healthy Volunteers: f

Study Arms:
- Atorvastatin, Ischemic Heart Disease (Type: OTHER): None
- Atorvastatin vs Placebo Cardiac Surgery (Type: PLACEBO_COMPARATOR): None

Based on this trial design, predict the completion outcome and termination type (if applicable).